Company Profile

Ontogen Corporation
Profile last edited on: 5/8/2017      CAGE:       UEI:

Business Identifier: Small-molecule therapeutic agents to fight cancer, infectious diseases and other chronic medical conditions
Year Founded
1992
First Award
2000
Latest Award
2002
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2325 Camino Vida Roble
Carlsbad, CA 92009
   (760) 930-0100
   sue.romano@ontogen.com
   N/A
Location: Single
Congr. District: 49
County: San Diego

Public Profile

Ontogen Corporation had been a drug discovery company. with a research program aimed at the development of novel small molecule therapeutics and at the creation of high-throughput discovery technologies. Ontogen Corporation's projects are in the area of cancer therapy, diabetes and inflammation. Coming afer impresisve listings of workingrelatonships wit majot players inthe field, during 2003, the firmwasreported to have hit serious bad times and laid off most of its workforce. Once can assme the firm quietly closed its doors shortly therafter

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
75-99
Revenue Range
7.5M-10M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2002 2 NIH $1,377,284
Project Title: Discovery of Novel Fructose Bisphosphatase Inhibitors

Key People / Management

  Barry E Toyonaga -- President

  R Michael Newman -- Executive Director of Biology

  Suzanne J Romano

Company News